16 Recruiting Sarcoma Phase 2 Clinical Trials
Active phase 2 studies for sarcoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Sarcoma studiesPhase 2 Studies for Sarcoma
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of Abemaciclib in Dedifferentiated Liposarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
📍 Memorial Sloan Kettering Cancer Center (only recruiting to the Vascular/Angiosarcoma cohort) — New York, New York
View Study & Checklist ➔A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
📍 Enable Medicine (Specimen Analysis Only) — Menlo Park, California
View Study & Checklist ➔A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
📍 Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Fluorescent Intra-operative Tumor Margin Examination
📍 UPMC-Shadyside Hospital — Pittsburgh, Pennsylvania
View Study & Checklist ➔Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
📍 UHN- Princess Margaret Cancer Center — Toronto, Ontario
View Study & Checklist ➔Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
📍 University Of Colorado Hospital — Aurora, Colorado
View Study & Checklist ➔Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
📍 Johns Hopkins All Children's Hospital — St. Petersburg, Florida
View Study & Checklist ➔Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
📍 Sarcoma Oncology Center — Santa Monica, California
View Study & Checklist ➔Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
📍 Memorial Sloan Kettering Basking Ridge (Limited protocol activities) — Basking Ridge, New Jersey
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
📍 GSK Investigational Site — Toronto, Ontario
View Study & Checklist ➔